At NuSkin, we are driven by a singular mission: to revolutionize skin disease diagnosis and improve patient outcomes. Founded and led by Dr. Nouri, a visionary leader with decades of experience in dermatology, NuSkin leverages cutting-edge technology to address critical needs in skin healthcare.
We have integrated three advanced imaging technologies – OCT, 3D imaging, and hyperspectral imaging – into a single, portable, and cost-effective device. Powered by sophisticated AI and machine learning algorithms, our technology provides unparalleled accuracy and speed in identifying potential skin cancers.
By utilizing the most comprehensive skin cancer databases from the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), NuSkin is at the forefront of developing the most advanced skin cancer diagnostic tool available. We believe that early detection is crucial for successful treatment and improved patient outcomes, and we are committed to empowering individuals and healthcare providers with the tools they need to achieve this goal.
